Subscribe To

Price Alert Latest News Economic Calendar News

LQDA / Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent

MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (PTAB) ruled in its favor in the Inter Partes Review (IPR) proceeding against U.S. Patent No. 9,604,901 (‘901 patent) owned by United Therapeutics Corporation (UTC) and listed in the Orange Book for Tyvaso® (treprostinil inhalation solution). Read More

Demo Live Account See Partner Details

Content Topics

Raven

Industries

Inc

Ravn

Liquidia

Receives

Favorable

Ruling

Partes

Review against

United

Therapeutics

Patent

Stock

LQDA

Posted: Oct 8 2021, 17:23

Author Name: GlobeNewsWire

LQDA News

By Zacks Investment Research
August 10, 2023

Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Tops Revenue Estimates

Liquidia Technologies, Inc. (LQDA) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.17. This comp

By GlobeNewsWire
August 3, 2023

Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023

MORRISVILLE, N.C., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its second quarter 2023 f

By Zacks Investment Research
June 29, 2023

Liquidia (LQDA) Up on Deal With Pharmosa to Co-Develop PH Drug

Liquidia (LQDA) signs an exclusive licensing agreement with Pharmosa to jointly develop and commercialize PAH and PH-ILD treatment candidate, L606, in

By Seeking Alpha
May 6, 2023

Liquidia Corporation (LQDA) Q1 2023 Earnings Call Transcript

Liquidia Corporation (NASDAQ:LQDA ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Jason Adair - SVP, Corporate Developme

By GlobeNewsWire
April 11, 2023

Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference

MORRISVILLE, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Michael Kaseta, Chief Financial Off

By Seeking Alpha
March 16, 2023

Liquidia Corporation (LQDA) Q4 2022 Earnings Call Transcript

Liquidia Corporation (NASDAQ:LQDA ) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Jason Adair - SVP, Corporate Devel

By Zacks Investment Research
March 16, 2023

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Tops Revenue Estimates

Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of 47.06% and 46.73%, respectively, for the quarter ended December 2022. D

By GlobeNewsWire
March 9, 2023

Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023

MORRISVILLE, N.C., March 09, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its full year 2022 finan

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.